B. Ku

J. Ahn, M. Ahn, Keunchil Park, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

4'-Acetoamido-4-hydroxychalcone, a chalcone derivative, inhibits glioma growth and invasion through regulation of the tropomyosin 1 gene.

Jungil Choi, S. Kang, K. Park, 2010, Biochemical and biophysical research communications.

Evaluation of MET alteration in EGFR-mutant non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor from paired biopsy: A retrospective cohort study

J. Ahn, M. Ahn, Yoon-La Choi, 2022, Precision and Future Medicine.

Acute ethanol administration decreases GAP-43 and phosphorylated-GAP-43 in the rat hippocampus

Hyun Joon Kim, S. Kang, G. Cho, 2006, Brain Research.

Ethanol-induced oxidative stress is mediated by p38 MAPK pathway in mouse hippocampal cells

Hyun Joon Kim, S. Kang, G. Cho, 2007, Neuroscience Letters.

Dynamics of circulating immune cells during chemoradiotherapy in patients with non-small cell lung cancer support earlier administration of anti-PD-1/PD-L1 therapy.

J. Ahn, M. Ahn, Keunchil Park, 2022, International journal of radiation oncology, biology, physics.

High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma

M. Ahn, Keunchil Park, Y. Ko, 2014, Journal of Translational Medicine.

CHI3L1 (YKL‐40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells

Jungil Choi, Hyun Joon Kim, S. Kang, 2011, International journal of cancer.

Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma

Jung-Il Lee, Y. Suh, J. Ahn, 2020, Nature Communications.

Resveratrol reduces TNF-α-induced U373MG human glioma cell invasion through regulating NF-κB activation and uPA/uPAR expression.

Jungil Choi, Dong Hoon Lee, Hyun Joon Kim, 2011, Anticancer research.

Topological Transformation‐Based Nanobarcoding for Detection and Enumeration of MicroRNAs and Single Nucleotide Polymorphism

Seung Won Shin, Soong Ho Um, Sang Hun Chun, 2019, Advanced biosystems.

Characteristics and Clinical Outcomes of Non-small Cell Lung Cancer Patients in Korea With MET Exon 14 Skipping

J. Ahn, M. Ahn, Keunchil Park, 2020, In Vivo.

Acquired resistance to AZD9291 as an upfront treatment is dependent on ERK signaling in a preclinical model

J. Ahn, M. Ahn, Keunchil Park, 2018, PloS one.

Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)

Ho Yun Lee, J. Ahn, M. Ahn, 2018, Journal of pathology and translational medicine.

An update on biomarkers for kinase inhibitor response in non-small-cell lung cancer

J. Ahn, M. Ahn, Keunchil Park, 2017, Expert review of molecular diagnostics.

An increase of CD8+ T cell infiltration following recurrence is a good prognosticator in HNSCC

M. Ahn, Y. Ko, Y. Son, 2020, Scientific Reports.

Caffeine inhibits cell proliferation and regulates PKA/GSK3β pathways in U87MG human glioma cells

Jungil Choi, Joon Soo Kim, Yong Woon Cho, 2011, Molecules and cells.

Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ

Seung Won Shin, Soong Ho Um, Kisuk Yang, 2017, Scientific Reports.

PD-1 blockade-unresponsive human tumor-infiltrating CD8+ T cells are marked by loss of CD28 expression and rescued by IL-15

M. Ahn, E. Shin, Hoyoung Lee, 2020, Cellular & Molecular Immunology.

AZD9291 overcomes T790 M-mediated resistance through degradation of EGFRL858R/T790M in non-small cell lung cancer cells

J. Ahn, M. Ahn, Keunchil Park, 2016, Investigational New Drugs.

A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non–Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib

J. Ahn, M. Ahn, Keunchil Park, 2015, Clinical Cancer Research.

The BIM Deletion Polymorphism and its Clinical Implication in Patients with EGFR-Mutant Non–Small-Cell Lung Cancer Treated with EGFR Tyrosine Kinase Inhibitors

J. Ahn, M. Ahn, Keunchil Park, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer

J. Ahn, M. Ahn, Keunchil Park, 2019, Investigational New Drugs.

KIF5B-MET Gene Rearrangement with Robust Antitumor Activity in Response to Crizotinib in Lung Adenocarcinoma.

J. Ahn, M. Ahn, Keunchil Park, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Characteristics and outcomes of RET-rearranged Korean non-small cell lung cancer patients in real-world practice.

J. Ahn, M. Ahn, Keunchil Park, 2020, Japanese journal of clinical oncology.

PKCη Regulates the TGFβ3-induced Chondevrepogenic Differentiation of Human Mesenchymal Stem Cell

Dong Hoon Lee, S. Kang, G. Cho, 2013, Development & reproduction.

MDSC subtypes and CD39 expression on CD8+ T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC

J. Ahn, M. Ahn, Keunchil Park, 2020, European journal of immunology.

BYL719, a selective inhibitor of phosphoinositide 3-Kinase α, enhances the effect of selumetinib (AZD6244, ARRY-142886) in KRAS-mutant non-small cell lung cancer

J. Ahn, M. Ahn, Keunchil Park, 2015, Investigational New Drugs.

ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer

J. Ahn, M. Ahn, Keunchil Park, 2021, Investigational New Drugs.

Paired analysis of tumor mutation burden calculated by targeted deep sequencing panel and whole exome sequencing in non-small cell lung cancer

M. Ahn, W. Park, Chung Lee, 2021, BMB reports.

The CDK4/6 inhibitor LY2835219 has potent activity in combination with mTOR inhibitor in head and neck squamous cell carcinoma

J. Ahn, M. Ahn, Keunchil Park, 2016, Oncotarget.

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models

D. Hong, Y. Gong, B. Ku, 2014, Journal of Cancer Research and Clinical Oncology.

Increased expression of transglutaminase 2 drives glycolytic metabolism in renal carcinoma cells

B. Ku, Chang-Hun Lee, Seon-Hyeong Lee, 2014, Amino Acids.

Heme oxygenase protects hippocampal neurons from ethanol-induced neurotoxicity

Hyun Joon Kim, S. Kang, G. Cho, 2006, Neuroscience Letters.

Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival.

D. Brat, S. Paek, S. Kang, 2010, Cancer research.

P2.14-61 Acquired Resistance to Entrectinib Associated with Activation of RAS Signaling Pathway in ROS1-Rearranged Non-Small Cell Lung Cancer

M. Ahn, Jong-Mu Sun, H. Jung, 2019, Journal of Thoracic Oncology.

High concordance of actionable genomic alterations identified between circulating tumor DNA–based and tissue‐based next‐generation sequencing testing in advanced non–small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program

J. Ahn, M. Ahn, Keunchil Park, 2021, Cancer.

Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs

J. Ahn, M. Ahn, Keunchil Park, 2020, Immune network.

Genetic Alterations and Their Clinical Implications in High-Recurrence Risk Papillary Thyroid Cancer

M. Ahn, Keunchil Park, J. Lee, 2016, Cancer research and treatment : official journal of Korean Cancer Association.

Longitudinal monitoring by next generation sequencing of plasma cell-free DNA in ALK-rearranged non-small cell lung cancer (NSCLC) patients treated with ALK tyrosine kinase inhibitors.

J. Ahn, M. Ahn, Keunchil Park, 2020 .

Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ

Seung Won Shin, Soong Ho Um, Yong Taik Lim, 2017, Scientific Reports.

EGFR C797S as a Resistance Mechanism of Lazertinib in Non-small Cell Lung Cancer with EGFR T790M Mutation

J. Ahn, M. Ahn, Keunchil Park, 2020, Cancer research and treatment : official journal of Korean Cancer Association.

Pembrolizumab for Patients With Refractory or Relapsed Thymic Epithelial Tumor: An Open-Label Phase II Trial.

J. Ahn, M. Ahn, Keunchil Park, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A phase II study of palbociclib for recurrent or refractory advanced thymic epithelial tumors (KCSG LU17-21).

J. Ahn, M. Ahn, Keunchil Park, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer

Hye Hyeon Eum, Jong-Mu Sun, J. Cho, 2024, bioRxiv.

Association of T cell senescence with radiation pneumonitis in patients with non-small cell lung cancer.

J. Ahn, M. Ahn, Keunchil Park, 2022, International journal of radiation oncology, biology, physics.